跳至主要内容
临床试验/NCT04849780
NCT04849780已完成不适用

Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact Lens

Johnson & Johnson Vision Care, Inc.18 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2021年4月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
95
试验地点
18
主要终点
Change From Baseline Comfort Score

研究概览

简要总结

This is a multi-site, randomized, bilateral, dispensing, parallel design study with two arms to evaluate contact lens related dry eye symptoms and subjective comfort.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Potential subjects must satisfy all of the following criteria to be enrolled in the study:
  • The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  • Appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • Between 18 and 59 (inclusive) years of age at the time of screening.
  • Be a daily disposable current soft contact lens wearer in both eyes with a minimum of 6 days/week wear time over the last 1 month by self-report.
  • Have a CLDEQ-8 score of 15 or greater with the habitual lens.
  • Subjects must possess a pair of spectacles for distance correction.
  • Subject's habitual lens must be the following lens types: Alcon DAILIES® Aqua Comfort Plus® , Alcon DAILIES TOTAL1®, CooperVision® clariti® 1 day, CooperVision® MyDay®, or Johnson & Johnson 1-Day ACUVUE® Moist.
  • The subject's vertex corrected spherical distance refraction must be in the range of -1.00 D to -6.00 D (inclusive) in each eye.
  • The magnitude of subject's vertex corrected refractive cylinder must be less than 1.00 diopter in each eye.
  • Have spherical best corrected visual acuity of 20/25 or better in each eye.

排除标准

  • Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • Subject's habitual lens is ACUVUE OASYS®1-Day.
  • Currently pregnant or lactating, by self-report.
  • Any ocular or systemic allergies, disease or use of medication which may interfere with contact lens wear (at the discretion of the investigator).
  • Any active ocular abnormalities/conditions that may interfere with contact lens wear (at the discretion of the investigator).
  • Any infectious diseases (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g. HIV), by self-report.
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • Habitual contact lens wear modality as extended wear (≥1 night per month of extended wear).
  • Habitual contact lens is rigid gas permeable, toric, monovision or multi-focal.
  • . Any previous, or planned (during the course of the study) ocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.).
  • Participation in any contact lens or lens care product clinical trial within 2 weeks prior to study enrollment.
  • Employee or employee's immediate family member of clinical site (e.g., Investigator, Coordinator, Technician).
  • Current habitual use of Restasis, Xiidra, ocular steroids, or any medication (Rx or over the counter (OTC)) that may interfere with contact lens wear (at the discretion of the investigator).
  • Any ocular allergies, infections or other ocular abnormalities that are known to interfere with contact lens wear and/or participation in the study. This may include, but not be limited to entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or corneal distortion.
  • Any Grade 3 or greater biomicroscopy findings (this includes, corneal edema, corneal staining, corneal vascularization, conjunctival injection, tarsal abnormalities, bulbar injection) on the FDA classification scale.

结局指标

主要结局

Change From Baseline Comfort Score

时间窗: Up to 2-Week Follow-up

Comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The change from baseline was calculated as 2-week follow-up minus baseline. The average change from baseline was reported for each arm. the change from baseline ranges from -120 to 120 where higher change from baseline comfort scores indicates a more favorable performance.

次要结局

  • CLDEQ-8 Score(2-Week Follow-up)
  • Comfort Score(2-Week Follow-up)
  • Change From Baseline CLDEQ-8 Score(Up to 2-Week Follow-up)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验

Evaluation of Dryness in a Silicone Hydrogel Daily... | 临床试验